Roundtable Discussion: Improving Consistency by Embedding Donor Selection into Early Autologous Cell Therapy Development
11:45 am - Thursday 3rd December 2026
- Identifying donor driven variability to reducing inconsistency in assays and final product quality
- Using donor characterisation to predicting manufacturing performance earlier in development
- Aligning cross functional decisions to minimising rework failed batches and variability in release
